<DOC>
	<DOC>NCT00658255</DOC>
	<brief_summary>The purpose of this study is to compare the therapeutic effects of formoterol in Symbicort with formoterol in Oxis Turbuhaler for the treatment of adults with stable asthma.</brief_summary>
	<brief_title>Relative Bronchodilating Effects of Formoterol When Administered Via Symbicort Pressurized Metered-dose Inhaler (pMDI) or Oxis Turbuhaler</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Budesonide, Formoterol Fumarate Drug Combination</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<criteria>At least 18 years of age Diagnosis of asthma and baseline lung function tests as determined by the protocol Required and received treatment with inhaled corticosteroids within timeframe and doses specified in the protocol Severe asthma Has required treatment with any noninhaled corticosteroids within previous 4 weeks, has sensitivity to drugs specified in protocol or requires treatment with betablockers</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>stable asthma</keyword>
	<keyword>adults</keyword>
	<keyword>formoterol</keyword>
	<keyword>Symbicort</keyword>
	<keyword>Oxis Turbuhaler</keyword>
	<keyword>bronchodilation</keyword>
</DOC>